ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:50 AM.
Here's what investors need to know about the announcement.
Earnings
ANI Pharmaceuticals missed estimated earnings by 233.33%, reporting an EPS of $-0.12 versus an estimate of $0.09.
Revenue was up $9.96 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.2 which was followed by a 7.26% drop in the share price the next day.
Here's a look at ANI Pharmaceuticals's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.74 | 0.70 | 0.68 | 0.71 |
| EPS Actual | 0.54 | 1.01 | 0.67 | 1.04 |
| Revenue Estimate | 56.30M | 49.70M | 48.05M | 46.80M |
| Revenue Actual | 60.93M | 52.06M | 48.62M | 54.52M |
To track all earnings releases for ANI Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
